$15.18 $0.36 per serving
Product analysis
Bacopa may support memory and learning over several weeks, though its unspecified preparation cannot be assumed to match the extracts behind those findings.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality20
The bacopa preparation is not specified well enough for a confident quality comparison. Named standardized extracts cannot be treated as interchangeable with every bacopa supplement.
Ingredient Transparency63
The bacopa amount is listed, allowing serving comparisons. Its form is omitted, limiting comparisons with particular extracts.
Value For Money100
The bacopa serving is competitively priced. Preparation differences still matter when comparing products with similar costs.
Customer Satisfaction73
Customer ratings are very positive. The relatively small review count leaves buyer opinion less settled.
Product Focus49
One active ingredient keeps the formula simple. Memory and learning findings depend on particular extracts and repeated use, limiting expectations for this unspecified preparation.
- Format
Liquid - Container
- 1 Liquid(s)
- Per serving
- $0.36
- Customer rating
- 4.6 · 339 ratings
Goals
Impact
Moderate effect
Bacopa · 647 mg
Impact
Lower effect
Impact
Moderate effect
Bacopa · 647 mg
Impact
Lower effect
Impact
Lower effect
Impact
Lower effect
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Bacopa monnieri Aerial Extract | 647 mg |
Bacopa · 647 mg OverallScore33
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Comparative effects of Bacopa monnieri and Ginkgo biloba on cognitive functions: A systematic review and network meta-analysis.
- Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract.
- Comparative efficacy of Medhya Rasayana,Bacopa monnieri, and Centella asiatica in enhancing memory and IQ of 8-10 year-old healthy boys: A prakriti-based double-blind, randomized controlled trial.
- Plant-derived nootropics and human cognition: A systematic review.
- The effect of plant active substances on cognitive function in healthy older adults: a systematic review and network meta-analysis of randomized controlled trials.
- The cognitive-enhancing effects of Bacopa monnieri: a systematic review of randomized, controlled human clinical trials.
- A systematic review of the Ayurvedic medicinal herb Bacopa monnieri in child and adolescent populations.
- Efficacy of Standardized Extract of Bacopa monnieri (Bacognize®) on Cognitive Functions of Medical Students: A Six-Week, Randomized Placebo-Controlled Trial.
- Evaluating the effects of Bacopa monnieri on cognitive performance and sleep quality of patients with mild cognitive impairment: A triple-blinded, randomized, placebo-controlled trial.
- Cognitive effects of two nutraceuticals Ginseng and Bacopa benchmarked against modafinil: a review and comparison of effect sizes.
- Efficiency of Different Supplements in Alleviating Symptoms of ADHD with or Without the Use of Stimulants: A Systematic Review.
- The Effects of a Bacopa monnieri Extract (Bacumen®) on Cognition, Stress, and Fatigue in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial.
- Effects of Bacopa monnieri (CDRI 08®) in a population of males exhibiting inattention and hyperactivity aged 6 to 14 years: A randomized, double-blind, placebo-controlled trial.
- The chronic effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy human subjects.
- Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial.
- Brahmi for the better? New findings challenging cognition and anti-anxiety effects of Brahmi (Bacopa monniera) in healthy adults.
- Examining the nootropic effects of a special extract of Bacopa monniera on human cognitive functioning: 90 day double-blind placebo-controlled randomized trial.
- An acute, double-blind, placebo-controlled crossover study of 320 mg and 640 mg doses of a special extract of Bacopa monnieri (CDRI 08) on sustained cognitive performance.
- Efficacy of Brahmi vati in generalised anxiety disorder - Randomized double blind comparative clinical trial.
- An acute, double-blind, placebo-controlled cross-over study of 320 mg and 640 mg doses of Bacopa monnieri (CDRI 08) on multitasking stress reactivity and mood.